3650 results for «397»

Filter By

3650 results

Transcatheter mitral valve repair for degenerative mitral regurgitation - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this live transmission from EuroPCR 2019 to discover the case of a 87 years-old female, who has been referred for degenerative mitral regurgitation. Watch it now to find out about the treatment's choice!

LIVE demonstration from Rigshospitalet, University of Copenhagen - Copenhagen, Denmark

Transcatheter mitral

Complex aortoiliac bifurcation treatment - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.

LIVE demonstration from Clinique Pasteur - Toulouse, France

Complex aortoiliac bifurcation

EuroPCR 2019 Closing Ceremony

24 May 2019 – From EuroPCR 2019

Consult this session to discover EuroPCR 2019 Closing Ceremony, where Andreas Baumbach - president of the EAPCI - highlights the key moments of the course, and what makes it unique.
Stay put: a surprise awaits you at the end!

That year, EuroPCR gathered 11,206 active participants; warm thanks to all...

EuroPCR 2019 Closing

TAVI in horizontal aorta

22 May 2019 – From EuroPCR 2019

Consult this session to discover a LIVE demonstration from St. Johannes Hospital - Dortmund, Germany, regarding TAVI in horizontal aorta, transmitted live during EuroPCR 2019. The patient here is a 78 years-old male presenting with progressive dyspnea (NYHA III) and angina pectoris (CCS-III), whose echography shows...

TAVI in horizontal aorta

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media

22 Dec 2020

This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.

IMPELLA single access technique: Introduction via social media

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques
Didn’t find what you were looking for?